Amgen to buy Celgene’s Otezla in $13.4bn deal
Deal helps advance Bristol-Myers Squibb’s $90bn takeover of rival biotech giant Celgene
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Pharmaceuticals